Adhikary KK,Lee HW .2011 .Nucleophilic substitution reactions of N-methyl α-Bromoacetanilides with benzylamines in dimethyl sulfoxide. Bull. Korean Chem. Soc., 32(3) : 857-862.
Akhtar R,Zahoor AF,Rasul A,Khan SG,Ali KG .2021 .In-vitro cytotoxic evaluation of newly designed ciprofloxacinoxadiazole hybrids against human liver tumor cell line (Huh7). Pak. J. Pharm. Sci., 34(3) : 1143-1148.
Berhe A,Russom M,Bahran F,Hagos G F .2019 .Ciprofloxacin and risk of hypolycemia in non-diabetic patients. J. Med. Case Rep, 13(1) : 142.
Cho NH,Shaw JE,Karuranga S,Huang Y,da Rocha Fernandes JD,Ohlrogge AW,Malanda B .2018 .IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res. Clin. Pract, 138 : 271-281.
Dash RP,Babu RJ,Srinivas NR .2018 .Reappraisal and perspectives of clinical drug-drug interaction potential of α-glucosidase inhibitors such as acarbose, voglibose and miglitol in the treatment of type 2 diabetes mellitus. Xenobiotica., 48(1) : 89-108.
El Ghandour S and Azar ST .2015 .Dysglycemia associated with quinolones. Prim. Care Diabetes, 9(3) : 168-171.
Gharib HM,Abajy MY,Omaren A .2020 .Investigating the effect of some fluoroquinolones on blood glucose and insulin levels in STZ-induced diabetic wistar rats. Res. J. Pharm. Technol., 13(12) : 5993-5998.
Granados J,Ceballos M,Amariles P .2018 .Hypo or hyperglycemia associated with fluoroquinolone use. Rev. Med, 146(5) : 618-626.
Jimenez-Montero JG .2007 .Am Diabetes Assoc2019. , : 2017.
Kulkarni S,Agarwal DK,Pallavi A .2017 .Development of a novel method for the analysis of the drug in low concentration using an antidiabetic drug 'Voglibose' for the study. J. Pharm. Res. Int., 19(2) : 1-9.
Mohammadi-Khanaposhtani M,Rezaei S,Khalifeh R,Imanparast S,Faramarzi MA,Bahadorikhalili S,Safavi M,Bandarian F,Esfahani EN,Mahdavi M,Larijani B M .2018 .- glucosidase inhibition and cytotoxic activities of acridine linked to thioacetamides as novel agents in treatment of type 2 diabetes. Bioorg. Chem, 80 : 288-295.
Okpana FO,Akah PA .2018 .. Effect of Diabetes on the Pharmacokinetic Profile of Fluoroquinolones. Int. J. Med, 6(2) : 21-27.
Oniga SD,Palage MD,Araniciu C,Marc G,Oniga O,Vlase L,Prisacari V,Valica V,Curlat S,Uncu L S .2018 .Design, synthesis, molecular docking and antibacterial activity evaluation of some novel norfloxacin analogues. Farmacia, 66(6) : 1048-1058.
Qian D,Zhang T,Zheng P,Liang Z,Wang S,Xie J,Zhao L,Zhang Y,Situ B Y .2018 .Comparison of oral antidiabetic drugs as add-on treatments in patients with type 2 diabetes uncontrolled on metformin: a network meta-analysis. Diabetes Ther., 9, (5) : 1945-1958.
Saad NA,Elberry AA,Samy Matar H,Hussein RR H .2021 .Effect of ciprofloxacin vs levofloxacin on QTc interval and dysglycemia in diabetic and non diabetic patients. Int. J. Clin. Pract, 75(5) : e14072.
Sabo A,Tomas A,Tomic N,Mikov M,Horvat O,Popovic R .2015 .Pharmacokinetic/ pharmacodynamic based dosing of ciprofloxacin in complicated urinary tract infections. Bangladesh J. Pharmacol., 10(3) : 621-626.
Saddique FA,Ahmad M,Ashfaq UA,Ahmad MN,Anjum MN,Mohsin NUA,Aslam S NUA .2019 .Alphaglucosidase inhibition and molecular docking studies of 1, 2-benzothiazine 1, 1-dioxide based carbohydrazides. Pak. J. Pharm. Sci., 32(6 Supp)) : 2829-2834.
Sohretoglu D,Sari S,Ozel A,Barut B .2017 .α- Glucosidase inhibitory effect of Potentilla astracanica and some isoflavones: Inhibition kinetics and mechanistic insights through in vitro and in silico studies. Int. J. Biol. Macromol, 105 : 1062-1070.
Sriram D,Yogeeswari P,Senchani G,Banerjee D G .2007 .Newer tetracycline derivatives: Synthesis, antiHIV, antimycobacterial activities and inhibition of HIV-1 integrase. Bioorg. Med, 17(8) : 2372-2375.
Suresh N,Nagesh HN,Renuka J,Rajput V,Sharma R,Khan IA,Gowri CSKV,- CSKV,- CSKV .2014 .-(4-(2-(4-substitutedpiperazin-1-yl) acetyl) piperazin-1-yl) quinoline-3-carboxylic acid derivatives as anti-tubercular and antibacterial agents. Eur. J. Med, 71 : 324-332.
Taj S,Ashfaq UA,Aslam S,Ahmad M,Bhatti SH .2019 .Alpha-glucosidase activity of novel pyrazolobenzothiazine 5, 5-dioxide derivatives for the treatment of diabetes mellitus. In vitro combined with molecular docking approach. , 74(11) : 1523-1530.
Teyhoo M,Hosseini F,Ardestani MS,Ghorbani M .2020 .Synthesis and evaluation of a novel nanosized anionic linear globular dendrimer G2-ciprofloxacin conjugate against prostate cancer. Pak. J. Pharm. Sci., 33(6) : 2589-2594.
Walayat K,Ahmad M,Rasul A,Aslam S,Anjum MN,Sultan S,Iqbal M .2020 .Synthesis, characterization and antimicrobial activity of norfloxacin based acetohydrazides. Pak. J. Pharm. Sci., 33(2) : 855-860.
Yadav V,Talwar P .2019 .Repositioning of fluoroquinolones from antibiotic to anti-cancer agents: An underestimated truth. Biomed, 111 : 934-946.
Zhang B,Watt JM,Cordiglieri C,Dammermann W,Mahon MF,Flügel A,Guse AH,Potter BV .2018 .Small molecule antagonists of NAADP-induced Ca 2+ release in T-Lymphocytes suggest potential therapeutic agents for autoimmune disease. Sci. Rep, 8(1) : 1-17.
Zhang GF,Liu X,Zhang S,Pan B,Liu ML .2018 .Ciprofloxacin derivatives and their antibacterial activities. Eur. J. Med, 146 : 599-612.